Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces…
Bavarian Nordic Reports Preliminary 2025 Financial Results and Provides Guidance for 2026
Exceeding latest 2025 guidance following a strong performance from both commercial arms…
Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results
Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million…
Upstream Bio Reports Positive Top-line Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma
February 11, 2026 06:00 ET | Source: Upstream Bio – Verekitug provided…
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
BOSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Bioxytran, Inc. (OTCQB: BIXT) today…
SEMI Reports 2025 Annual Worldwide Silicon Wafer Shipments and Revenue Results
Shipments Increase in 2025 Amid Strong AI-driven Demand, While Revenue SoftensMILPITAS, Calif.,…
MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, an Oral Multi-Targeted Investigational Therapy for Alzheimer’s Disease
TAINAN, Feb. 10, 2026 /PRNewswire/ -- MerryLife Biomedical Inc., a clinical-stage biotechnology…
Aptean Unveils Aptean Intelligence as a Service, Delivering IndustryReady AI Agents That Drive Real Operational Results
ALPHARETTA, Ga., Feb. 09, 2026 (GLOBE NEWSWIRE) -- As manufacturers and distributors…
Mawson Infrastructure Group Inc. Releases Preliminary Unaudited Results for Fourth Quarter and Fiscal Year 2025
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large…
HUTCHMED to Announce 2025 Final Results
February 06, 2026 03:30 ET | Source: HUTCHMED (China) Limited HONG KONG…
